US Stem Cell Research is Being Hindered by Rush for Patents

by Kathy Jones on  January 26, 2011 at 6:25 PM Genetics & Stem Cells News
  •   Print
  •   Share
  •   Comments
  •  Text 
Experts have said that cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked by the US rush to secure patents.

Scientists are busily filing for legal patents that give them exclusive intellectual property rights for each discovery they make in the hopes that one day, one will lead to a blockbuster cure and big cash for those who devised it.

But the process means that US scientists -- already stymied by years of government funding freezes linked to controversy over the destruction of human embryos -- often find themselves blocked because other universities or private companies have already secured exclusive rights.

"You just have this complete minefield out there and you know who the victims are? It's the patients," said Bob Lanza, chief scientific officer at Advanced Cell Technology, which is researching the use of human embryonic stem cells to halt some forms of blindness.

Lanza recalls bumping up against his company's main competitor, Geron Corporation, when it came to researching stem cells in reversing diabetes, a process he said he had been working on with animals for many years.

"When I came to ACT to try to do it with stem cells I couldn't because the rights to use embryonic stem cells for diabetes had been exclusively licensed to Geron," he said.

"Here I was, a scientist trying to cure diabetes and I couldn't use my entire lifetime of expertise to try and develop that technology," he said.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

patent_litigation(Guest)

02/07/2011

I would like to see more attention paid in the U.S. to compulsory licensing of patents, at least in certain cases that deal with life-saving medical treatment and/or the containment of a public health threat. http://www.youtube.com/watch?v=YZT-WQI3SfI



MichaelMedanejul(Guest)

01/27/2011

Oddly enough this will be great for ACTC's stock price. Advanced Cell just received FDA clearance for clinical trials to treat patients with macular degeneration. If the trials prove a success, it will be an absolutely remarkable milestone in the field of stem-cell research.



01/27/2011

The patent trolls who stifle innovation that can improve and save lives should be treated as criminals.




X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Senior Health Center

Genetics & Stem Cells Related News

» Way to Delay Aging of Stem Cells Identified » Genetic Traits Likely to Predispose Voters to Elect a Specific Candidate
» Gene Behind Chronic Inflammation Accelerated Aging and Cancer Identified » Discovery Of Male Fertility Genes
» Disease Risk Prediction may Not be Improved by Genetic Information » Scientists Map Gene Sequence of Drug Resistant VRSA
» Marker in Premies' Saliva Predicts Readiness to Feed by Mouth » Recovery From MS Maybe With Growth Factor In Stem Cells
Read More >>